Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cédric Ménard

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Medecine Sciences : M/S|March 31, 2011
[Immunosuppression and mesenchymal stem cells: back to the future]Cédric Ménard, Karin Tarte
Stem Cell Research & Therapy|June 8, 2013
Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical applicationCédric Ménard, Karin Tarte
Respirology (Carlton, Vic.)|May 5, 2020
Pulmonary alveolar proteinosisStéphane Jouneau, Cédric Ménard, Mathieu Lederlin
Immunological Reviews|November 15, 2006
The role of regulatory T cells in the control of natural killer cells: relevance during tumor progressionFrancois Ghiringhelli, Cédric Ménard, Francois Martin, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 21, 2009
Imatinib mesylate (Gleevec): targeted therapy against cancer with immune propertiesMoustapha Zoubir, Thomas Tursz, Cédric Ménard, et al.
Aesthetic Plastic Surgery|December 17, 2013
Medial thighplasty after massive weight loss: are there any risk factors for postoperative complications?Nicolas Bertheuil, Sophie Thienot, Vincent Huguier, et al.
Cancer Immunology, Immunotherapy : CII|March 29, 2008
Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunityCédric Ménard, François Martin, Lionel Apetoh, et al.
Bulletin Du Cancer|January 1, 2019
Alexandra Frelau, Marc Pracht, Samuel Le Sourd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Ctla-4 blockade confers lymphocyte resistance to regulatory T-cells in advanced melanoma: surrogate marker of efficacy of tremelimumab?Cédric Ménard, François Ghiringhelli, Stephan Roux, et al.
Cytokine & Growth Factor Reviews|December 25, 2007
Dendritic cells and innate defense against tumor cellsEvelyn Ullrich, Cédric Ménard, Caroline Flament, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Medecine Sciences : M/S|March 31, 2011
[Immunosuppression and mesenchymal stem cells: back to the future]Cédric Ménard, Karin Tarte
Stem Cell Research & Therapy|June 8, 2013
Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical applicationCédric Ménard, Karin Tarte
Respirology (Carlton, Vic.)|May 5, 2020
Pulmonary alveolar proteinosisStéphane Jouneau, Cédric Ménard, Mathieu Lederlin
Immunological Reviews|November 15, 2006
The role of regulatory T cells in the control of natural killer cells: relevance during tumor progressionFrancois Ghiringhelli, Cédric Ménard, Francois Martin, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 21, 2009
Imatinib mesylate (Gleevec): targeted therapy against cancer with immune propertiesMoustapha Zoubir, Thomas Tursz, Cédric Ménard, et al.
Aesthetic Plastic Surgery|December 17, 2013
Medial thighplasty after massive weight loss: are there any risk factors for postoperative complications?Nicolas Bertheuil, Sophie Thienot, Vincent Huguier, et al.
Cancer Immunology, Immunotherapy : CII|March 29, 2008
Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunityCédric Ménard, François Martin, Lionel Apetoh, et al.
Bulletin Du Cancer|January 1, 2019
Alexandra Frelau, Marc Pracht, Samuel Le Sourd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Ctla-4 blockade confers lymphocyte resistance to regulatory T-cells in advanced melanoma: surrogate marker of efficacy of tremelimumab?Cédric Ménard, François Ghiringhelli, Stephan Roux, et al.
Cytokine & Growth Factor Reviews|December 25, 2007
Dendritic cells and innate defense against tumor cellsEvelyn Ullrich, Cédric Ménard, Caroline Flament, et al.
Pageof 3